MOLLY WILLIAMS: Open Payments
NPI 1457866253 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 29 payments from 15 companies in 2025. Trend: 2023 $1,499 · 2024 $1,241 · 2025 $535
Food & beverage: $535
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $88 |
| E.R. Squibb & Sons, L.L.C. | 3 | $59 |
| Novo Nordisk Inc | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| Amgen Inc. | 3 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $36 |
| Boston Scientific Corporation | 1 | $32 |
| Organogenesis Inc. | 1 | $27 |
| Inspire Medical Systems, Inc. | 1 | $25 |
Products named: CAMZYOS, Wegovy, JARDIANCE, REPATHA, ELIQUIS, VYNDAQEL, Kerendia, MOUNJARO.
Industry payments across MO — which companies pay providers there.
